The Best REIPro Alternative for Real Estate Investors
REIPro manages your pipeline. DealAnalyzerAI supports underwriting review with ARV estimates, preliminary photo-based rehab screening, and deal factors.
- Free ARV range — no credit card required
- One free ARV range; full property analyses are paid
- AI ARV, rehab & 1–100 deal scoring
- Comparable-property analysis from available data
AI-Powered ARV Estimation
Get After Repair Value estimates from comparable sales analysis — no manual comp research or guesswork.
Preliminary Photo-Based Rehab Screening
Use listing photos to review visible condition; verify repairs with an inspection and contractor bids.
Deal Scoring (1–100)
A single score that summarizes ROI, risk factors, and market suitability — pursue or pass with confidence.
Full Calculator Suite
ARV, MAO, fix & flip, BRRRR, rental cash flow, and cap rate calculators in one platform.
Investor-Ready Reports
Professional, shareable reports for lenders, partners, or wholesale buyers — white-label available.
Structured Deal Screening
Review deal assumptions in a consistent workflow before further due diligence.
What REIPro Does vs. What DealAnalyzerAI Does
REIPro is an all-in-one real estate investor CRM: lead management, marketing campaigns, direct mail, workflows, and basic deal analysis worksheets. If you need a system to manage seller leads and follow-up, REIPro covers a lot of ground.
The gap: REIPro's deal analysis relies on the numbers you type in. It doesn't generate an ARV from comparable sales for you, estimate rehab costs from photos, or score deal quality. The underwriting is only as good as your manual inputs.
DealAnalyzerAI is a dedicated underwriting engine. It produces the inputs — an AI-estimated ARV range from real comps, a photo-based rehab estimate, and a maximum allowable offer — then scores the deal so you know whether to pursue or pass. Many investors run their pipeline in a CRM and underwrite every serious lead in DealAnalyzerAI.
Feature Comparison
| Capability | DealAnalyzerAI | REIPro |
|---|---|---|
| AI ARV estimation from comparable sales | ✅ Yes | ❌ Manual entry |
| Photo-based rehab cost estimates | ✅ Yes | ❌ No |
| Deal scoring (1–100) | ✅ Yes | ❌ No |
| MAO / 70% rule calculator | ✅ Yes | ✅ Worksheets |
| Rental cash flow, cap rate & BRRRR analysis | ✅ Yes | ✅ Basic |
| Lead management / CRM & direct mail | ❌ No | ✅ Yes |
| White-label investor reports | ✅ Yes | ❌ No |
| Free public ARV range | ✅ One range; email unlocks a limited aggregate summary | Verify current offer |
Pricing: DealAnalyzerAI provides one public ARV range; Pay As You Go full analyses are $0.97 each, minimum 10 ($9.70), with prepaid credits that never expire. Growth is $37/month for 50 analyses and Pro is $97/month for 300. White Label is a $50/month add-on. REIPro's published pricing should be verified on their site before comparing — plans and promotions change.
Who Benefits Most from DealAnalyzerAI
DealAnalyzerAI is the stronger choice for investors who:
- Already have leads and need underwriting structure — review deal assumptions in a consistent workflow
- Review available information remotely — use photo-based estimates as a preliminary screen, then verify condition and costs locally
- Want structured ARV estimates — review comparable-sale information alongside your own due diligence
- Prepare reports for lenders or end buyers — professional, white-label-ready output
REIPro remains a reasonable choice if your bottleneck is lead management and marketing rather than deal analysis — and the two tools can be used together.
Frequently Asked Questions
Get My Free ARV Range
Join thousands of investors making smarter real estate decisions.
Get My Free ARV RangeRelated Calculators
Continue your research
Review the tools and guides most relevant to this analysis.